Follow the people · Insider

DP

Derrell Porter

Insider · Director · ABOS

Derrell Porter files insider transactions with the SEC as a director of Acumen Pharmaceuticals (ABOS). We hold 3 disclosed purchases and sales filed since 11 May 2017, 3 of them in the last 90 days.

  • Files forABOS
  • Disclosed buys and sells3 in all, 3 in the last 90 days
  • Last disclosure17 June 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 4 January 202317 June 2026Director · Acumen Pharmaceuticals (ABOS)14 Form 4 lines · source: SEC Form 4
  • Filed 27 May 202119 May 2026Director · Passage BIO (PASG)6 Form 4 lines · source: SEC Form 4
  • Filed 10 May 201726 March 2019SVP, Head of Global Commercial · Atara Biotherapeutics (ATRA)14 Form 4 lines · source: SEC Form 4

Everything they disclosed

34 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.